SHP2 has been identified as a tumor suppressor in hepatocellular malignancies, and the inhibition of SHP2 when ARSB is reduced is consistent with the role of ARSB as a tumor suppressor [21–25,39]. This evidence concerns the gene PTPN11 and neoplasm.